Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study.
Yoonseok LeeSeryun BaeJi Hoon KimMinjung KwakSo Yeon JeonTae-Hyung KimSun Young YimYoung-Sun LeeYoung-Kul JungYeon Seok SeoHyung Joon YimJong Eun YeonKwan Soo ByunPublished in: Journal of clinical medicine (2023)
Serum AsAGP levels in CHB patients with LC were significantly higher than those in healthy controls and CHB patients. AsAGP levels showed good diagnostic performance in predicting advanced fibrosis and cirrhosis, which suggests a potential role as a biomarker for predicting the progression of liver disease in CHB.